Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat

European Journal of Pharmacology

Volumn 313, Issue 1-2, 1996, Pages 17-24

  Costa, Barbara ^a   Parolaro, Daniela ^a   Colleoni, Mariapia ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Biotransformation; Cannabinoid; CP 55,940; Energetic metabolism; Tolerance

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID; CITRATE SYNTHASE; CYTOCHROME P450; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BEHAVIOR; BRAIN MITOCHONDRION; CONTROLLED STUDY; DRUG TOLERANCE; DRUG TRANSFORMATION; ENERGY METABOLISM; ENZYME ACTIVITY; FOOD INTAKE; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER MITOCHONDRION; LOCOMOTION; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; RAT; WEIGHT REDUCTION;

EID: 0030579091     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00499-2     Document Type: Article

References (50)

1. Banerji, A., M.K. Poddar and J.J. Ghosh, 1985, Delta-9-tetrahydrocannabinol: effect on mitochondrial swelling of different tissues of rat, Methods Find. Exp. Clin. Pharmacol. 7, 351.
2. 1-tetra-hydrocannabinol, Biochim. Biophys. Acta 288, 195.
3. Bornheim, L.M. and M.A. Correia, 1989a, Effect of cannabidiol on cytochrome P-450 isozymes, Biochem. Pharmacol. 38, 2789.
4. Bornheim, L.M. and M.A. Correia, 1989b, Purification and characterization of a mouse liver cytochrome P-450 induced by cannabidiol, Mol. Pharmacol. 36, 377.
5. 9-tetra-hydrocannabinol with the hepatic microsomal drug metabolizing system, Life Sci. 10, 1207.
6. Colleoni, M., B. Costa, E. Gori and A. Santagostino, 1996, Biochemical characterization of the effects of the benzodiazepine, midazolam, on mitochondrial electron transfer, Pharmacol. Toxicol. 78, 69.
7. Compton, D.R., W.L. Dewey and B.R. Martin, 1990, Cannabis dependence and tolerance production, in: Addiction Potential of Abused Drugs and Drug Classes, eds. C.K. Erickson, M.A. Iavors, W.W. Morgan and B. Stimmel (The Hayworth Press, New York) p. 129.
8. D'Amour, F.E. and D.L. Smith, 1941, A method for determining loss of pain sensation, J. Pharmacol. Exp. Ther. 72, 74.
9. Davis, L.F., E.E. Gatz and J.R. Jones, 1974, Effects of chlorodiazepoxide and diazepam on respiration and oxidative phosphorylation in rat brain mitochondria, Biochem. Pharmacol. 20, 1883.
10. Devane, W.A., F.A.I. Dysarz, M.R. Johnson, L.S. Melvin and A.C. Howlett, 1988, Determination and characterization of a cannabinoid receptor in rat brain, Mol. Pharmacol. 34, 605.
11. Dewey, W.L., 1986, Cannabinoid pharmacology, Pharmacol. Rev. 38, 151.
12. 9-tetrahydrocannabinol, Biochem. Pharmacol. 22, 399.
13. Fan, F., K. Tao, M. Abood and B.R. Martin, 1996, Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP-55,940 on adenylyl cyclase in the cerebellum of CP-55,940-tolerant mice, Brain Res. 706, 13.
14. Fernandes, M., N. Warning, W. Christ and R. Hill, 1973, Interations of several cannabinoids with the hepatic drug metabolizing system, Biochem. Pharmacol. 22, 2981.
15. 9-tetrahydrocannabinol, Brain Res. 697, 83.
16. Garfinkel, D., 1958, Studies on pig liver microsomes, I. Enzymic and pigment composition of different microsomal tractions, Arch. Biochem. Biophys. 77, 493.
17. Greenlee, W.F. and A. Poland, 1978, An improved assay of 7-ethoxycoumarin O-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholantrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin, J. Pharmacol. Exp. Ther. 205, 596.
18. Herkenham, M., A.B. Lynn, M.D. Little, M.R. Johnson, L.S. Melvin, B.R. de Costa and K.C. Rice, 1990, Cannabinoid receptor localization in brain, Proc. Natl. Acad. Sci. USA 87, 1932
19. Hissin, P.J. and R. Hilf, 1976, A fluorimetric method for determination of oxidized and reduced glutathione in tissues, Anal. Biochem. 74, 214.
20. Howlett, A.C., M. Bidaut-Russell, W.A. Devane, L.S. Melvin, M.R. Johnson and M. Herkenham, 1990, The cannabinoid receptor: biochemical, anatomical and behavioural characterization, Trends Neurosci. 13, 420.
21. Johnson, M.R. and L.S. Melvin, 1986, The discovery of nonclassical cannabinoid analgetics, in: Cannabinoids and Therapeutic Agents, ed. R. Mechoulam (CRC Press, Boca Raton), p. 121.
22. Karler, R., H.K. Borys and S.A. Turkanis, 1982, Influence of 22-day treatment on the anticonvulsant properties of cannabinoids, Naunyn Schmiedeberg's Arch. Pharmacol. 320, 105.
23. Khanna, P., M.B. Gupta, G.P. Gupta, G.G. Sanwai and B. Ali, 1991, Influence of chronic oral intake of cannabis extract on oxidative and hydrolitic metabolism of xenobiotics in rat, Biochem. Pharmacol. 41, 109.
24. Leighty, E.G., 1979, Comparison of the effects of 11-palmitoyloxi-Δ9-tetrahydrocannabinol and 11-hydroxy-Δ9-tetrahydrocannabinol on the hepatic microsomal drug-metabolizing enzyme system, Res. Commun. Chem. Pathol. Pharmacol. 25, 525.
25. Lemberger, L., 1972, The metabolism of tetrahydrocannabinols, in: Advances in Pharmacology and Chemotherapy, eds. S. Garattini et al. (Academic Press. New York) p. 221.
26. Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall, 1951, Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265.
27. Magour, S., H. Coper and C. Fahndrich, 1977, Is tolerance to delta-9-THC cellular or metabolic?, Psycopharmacology 51, 141.
28. 9-tetrahydrocannabinol on mitochondrial processes, Biochem. Pharmacol. 21, 1217.
29. Martin, B.R., D.R. Compton, B.F. Thomas, W.R. Prescott, P.J. Little, R.K. Razdan, M.R. Johnson, L.S. Melvin, R. Mechoulam and S.J. Ward, 1991, Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs, Pharmacol. Biochem. Behav. 40, 471.
30. 9-tetrahydrocannabinol and its metabolites in tolerant and nontolerant pigeons, Biochem. Pharmacol. 22, 383.
31. Mitoma, C., H.S. Posner, H.C. Reit and S. Udenfriend, 1956, Enzymatic hydroxylation of aromatic compounds, Arch. Biochim. Biophys. 61, 431.
32. 9-tetrahydrocannabinol on rat liver microsomal drug-metabolizing enzymes, Toxicol. Appl. Pharmacol. 35, 523.
33. 9-THC as measured by the response of a cellular function, Life Sci. 14, 2513.
34. Nebert, D.W. and H.V. Gelboin, 1968, Substrate inducible microsomal aryl-hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme, J. Biol. Chem. 243, 6242.
35. Omura, T. and R. Sato, 1964, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature, J. Biol. Chem. 239, 2370.
36. 5 and NADPH-cytochrome c reductase from liver microsomes, J. Biochem. 67, 249.
37. Oviedo, A., J. Glowa and M. Herkenham, 1993, Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study, Brain Res. 616, 293.
38. Pertwee, R.G., 1991, Tolerance to and dependence on psycotropic cannabinoids, in: The Biological Basis of Drug Tolerance and Dependence, ed. J.A. Pratt (Academic Press, London), p. 231.
39. Pertwee, R.G., 1993, The evidence for the existence of cannabinoid receptors, Gen. Pharmac. 24, 811.
40. Poddar, M.K. and J.J. Ghosh, 1976, Neuronal membrane as the site of action of delta-9-THC, Pharmacol. Cannabis 1, 157.
41. 9-tetrahydrocannabinol treatment, Pharmacol. Biochem. Behav. 47, 33.
42. Rubino, T., P. Massi, G. Patrini, I. Venier, G. Giagnoni and D. Parolaro, 1994. Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study, NeuroReport 5, 2493.
43. Santagostino, A., M. Colleoni, E. Arias, N. Pacces-Zaffaroni and T. Zavanella, 1989, Changes in catalase, glutathione peroxidase and glutathione-S-transferase activities in the liver of newts exposed to 2-methyl-4-chlorophenoxyacetic acid (MCPA), Pharmacol. Toxicol. 65, 136.
44. 9-tetrahydrocannabinol and ethanol: the role of drug disposition, Pharmacol. Biochem. Behav. 10, 49.
45. Sprague, R.A. and A.L. Craigmill, 1976, Ethanol and Delta-9-tetrahydrocannabinol: mechanism for cross-tolerance in mice, Pharmacol. Biochem. Behav. 5, 409.
46. 9-tetrahydrocannabinol, Fed. Proc. 31, 909.
47. Uemura, T., E. Chiesara and D. Cova, 1977, Interaction of epinephrine metabolites with the liver microsomal electron transport system, Mol. Pharmacol. 13, 196.
48. Wendel, A., 1981, Glutathione peroxidase, in: Methods in Enzymology, Vol. 77, ed. W.B. Jacobi (Academic Press, New York) p. 325.
49. 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors, Brain Res. 544, 145.
50. Zar, J.H., 1974, Biostatistical Analysis, eds. W.D. McElroy and C.P. Swanson (Prentice-Hall, Englewood Cliffs).